DXC (DXC) Q1 Revenue Tops Estimates

DXC Technology reported mixed Q1 FY2026 results, with GAAP revenue of $3.16 billion and non-GAAP EPS of $0.68 both exceeding analyst estimates, yet revenue declined 2.4% and non-GAAP EPS fell 9.3% year-over-year. A significant positive was a 14% increase in bookings to $2.8 billion, marking a third consecutive quarter of double-digit growth, alongside a more than doubling of non-GAAP free cash flow to $97 million. Despite ongoing revenue and margin pressures, the company raised its full-year FY2026 non-GAAP EPS guidance, though it still anticipates a 3.0%-5.0% organic revenue decline, reflecting continued strategic investments in AI and talent.

Analysis

DXC Technology reported mixed Q1 FY2026 results, exceeding analyst expectations on revenue and non-GAAP EPS with figures of $3.16 billion and $0.68, respectively. However, these beats were overshadowed by underlying weakness, including a 2.4% year-over-year decline in GAAP revenue and a 9.3% drop in non-GAAP EPS. A significant positive is the 14% year-over-year increase in bookings to $2.8 billion, marking the third consecutive quarter of double-digit growth and signaling a potentially strong future revenue pipeline. Profitability remains a key concern, as evidenced by a decline in adjusted EBIT margin to 6.8% and sharp profit contractions in key segments; notably, the Insurance Services segment saw profit fall 25% despite revenue growth, and the Consulting and Engineering margin dropped to 8.4%. On a positive liquidity note, non-GAAP free cash flow more than doubled year-over-year to $97 million, and the company returned $50 million to shareholders via repurchases. Management's decision to raise full-year non-GAAP EPS guidance to a range of $2.85–$3.35 is encouraging, but it is tempered by a forecast for a 3.0% to 5.0% decline in full-year organic revenue, underscoring the ongoing challenge of translating new business into top-line growth.

Key Decisions for Investors

• Investors should prioritize monitoring the conversion rate of the strong $2.8 billion in quarterly bookings into recognized revenue, as this is the primary catalyst required to reverse the ongoing organic revenue decline.
• Careful scrutiny of segment-level profitability is warranted, particularly in the Insurance and Consulting divisions, to assess whether strategic investments in talent and AI are yielding margin improvements or continuing to pressure overall EBIT.
• While the raised EPS guidance and strong free cash flow may attract value-oriented investors, the persistent revenue contraction and margin pressures present a significant execution risk, suggesting a cautious stance may be prudent until a clear inflection in organic growth is evident.